AVITA Medical (RCEL) grants options and RSUs to Chief Legal Officer
Rhea-AI Filing Summary
AVITA Medical, Inc. reported that Chief Legal Officer Nicole Kelsey received equity awards consisting of stock options and restricted stock units. She was granted stock options for 145,060 shares at an exercise price of $0.0000 per share and 98,390 shares of Common Stock through restricted stock units.
The restricted stock units each represent the right to receive one share of Common Stock and vest in three equal annual installments beginning 12 months after the February 18, 2026 grant date. The stock options vest in three equal annual installments beginning on the first anniversary of the February 18, 2026 grant date, aligning the awards with multi-year service and performance.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 98,390 shares
Net Buy
2 txns
Insider
KELSEY NICOLE
Role
Chief Legal Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 145,060 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 98,390 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options (Right to Buy) — 145,060 shares (Direct);
Common Stock — 98,390 shares (Direct)
Footnotes (3)
- F1. Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments beginning on the date 12 months following the grant date of February 18, 2026.
- F2. Includes unvested RSUs.
- F3. These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date of February 18, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did AVITA Medical (RCEL) report for Nicole Kelsey?
AVITA Medical reported that Chief Legal Officer Nicole Kelsey acquired equity awards through grants, not open-market purchases. She received stock options and restricted stock units under company compensation, reflecting non-cash incentive awards tied to continued service and time-based vesting conditions over several years.
How many stock options were granted to Nicole Kelsey at AVITA Medical (RCEL)?
Nicole Kelsey was granted stock options covering 145,060 shares of AVITA Medical Common Stock. These options have an exercise price of $0.0000 per share and vest in three equal annual installments, starting on the first anniversary of the February 18, 2026 grant date.
What restricted stock unit award did Nicole Kelsey receive from AVITA Medical (RCEL)?
She received an award of 98,390 restricted stock units, each representing a contingent right to one AVITA Medical Common share. These RSUs are subject to time-based vesting, in three equal annual installments beginning 12 months after the February 18, 2026 grant date.
Are Nicole Kelsey’s AVITA Medical (RCEL) equity awards immediately vested?
No, both the restricted stock units and stock options are subject to time-based vesting. The RSUs vest in three equal annual installments starting 12 months after grant, while the options vest in three equal annual installments from the first grant anniversary.
Does Nicole Kelsey’s Form 4 for AVITA Medical (RCEL) involve any stock sales?
The Form 4 shows only grant or award acquisitions, not sales. It reports awards of stock options and restricted stock units at an exercise price of $0.0000, reflecting compensation rather than any disposition of AVITA Medical Common Stock.
What does “Includes unvested RSUs” mean in Nicole Kelsey’s AVITA Medical (RCEL) holdings?
The phrase indicates that the reported total Common Stock-related holdings for Nicole Kelsey include restricted stock units that have not yet vested. These unvested RSUs still depend on satisfying future time-based vesting conditions before shares are actually delivered.